Cargando…

Targeting CDK1 in cancer: mechanisms and implications

Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as promising candidate targets for cancer treatment. These proteins complexed with cyclins play a critical role in cell cycle progression. Most CDKs demonstrate substantially higher expression in cancer tissues compared w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiushi, Bode, Ann M., Zhang, Tianshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264400/ https://www.ncbi.nlm.nih.gov/pubmed/37311884 http://dx.doi.org/10.1038/s41698-023-00407-7

Ejemplares similares

Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy
por: Wang, Qiushi, et al.
Publicado: (2022)

Recent Advances in Carcinogenesis Transcription Factors: Biomarkers and Targeted Therapies
por: Bode, Ann M., et al.
Publicado: (2023)

HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E
por: Chang, Xiaoyu, et al.
Publicado: (2020)

An overview of Cdk1-controlled targets and processes
por: Enserink, Jorrit M, et al.
Publicado: (2010)

Targeting CDK9 for Anti-Cancer Therapeutics
por: Mandal, Ranadip, et al.
Publicado: (2021)

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development
por: Zhang, Tianshun, et al.
Publicado: (2019)

Mechanisms and Implications of CDK4/6 Inhibitors for the Treatment of NSCLC
por: Zhang, Jinmeng, et al.
Publicado: (2021)

Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer
por: Decker, Joseph T., et al.
Publicado: (2021)

Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
por: Oner, Muhammet, et al.
Publicado: (2019)

Biological functions of CDK5 and potential CDK5 targeted clinical treatments
por: Shupp, Alison, et al.
Publicado: (2017)

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
por: Wood, Daniel J., et al.
Publicado: (2019)

Targeting CDK9 for the Treatment of Glioblastoma
por: Ranjan, Alice, et al.
Publicado: (2021)

Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2
por: Li, Yan, et al.
Publicado: (2015)

The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
por: Liu, Ziying, et al.
Publicado: (2023)

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
por: Kang, Jian, et al.
Publicado: (2014)

Targeting CDK4/6 for Anticancer Therapy
por: Qi, Jiating, et al.
Publicado: (2022)

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
por: Piezzo, Michela, et al.
Publicado: (2020)

CDK12: A Potent Target and Biomarker for Human Cancer Therapy
por: Liang, Shujing, et al.
Publicado: (2020)

Targeting CDK9 for treatment of colorectal cancer
por: Rahaman, Muhammed H., et al.
Publicado: (2019)

Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
por: Cheng, Can, et al.
Publicado: (2019)

Posttranslational regulation of PGC‐1α and its implication in cancer metabolism
por: Luo, Xiangjian, et al.
Publicado: (2019)

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
por: Sun, Ran, et al.
Publicado: (2022)

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

Temporal changes in cyclinD-CDK4/CDK6 and cyclinE-CDK2 pathways: implications for the mechanism of deficient decidualization in an immune-based mouse model of unexplained recurrent spontaneous abortion
por: Chang, Zhuo, et al.
Publicado: (2022)

CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
por: Ying, Xue, et al.
Publicado: (2021)

CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
por: Nardone, Valerio, et al.
Publicado: (2021)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

High Iodine Induces the Proliferation of Papillary and Anaplastic Thyroid Cancer Cells via AKT/Wee1/CDK1 Axis
por: Lv, Chunpeng, et al.
Publicado: (2021)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

The role of CDK6 in cancer
por: Nebenfuehr, Sofie, et al.
Publicado: (2020)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

Getting to S: CDK functions and targets on the path to cell-cycle commitment
por: Fisher, Robert P.
Publicado: (2016)

Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia
por: Porazzi, Patrizia, et al.
Publicado: (2021)

Regulatory functions of the Mediator kinases CDK8 and CDK19
por: Fant, Charli B., et al.
Publicado: (2018)

Targeted Therapy in HR+ HER2− Metastatic Breast Cancer: Current Clinical Trials and Their Implications for CDK4/6 Inhibitor Therapy and beyond Treatment Options
por: Elfgen, Constanze, et al.
Publicado: (2021)

The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells
por: Zhang, Ruitao, et al.
Publicado: (2017)

Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice
por: McCartney, Amelia, et al.
Publicado: (2019)

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
por: Finn, Richard S., et al.
Publicado: (2016)

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bb7shdj25hkdo1trnf0omgk6s5